IQVIA Announces Offering of Senior Notes
February 16 2021 - 3:26AM
Business Wire
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that
its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to
raise €1,450,000,000 in gross proceeds (equivalent to approximately
$1,761,000,000) through an offering of senior notes due 2026 and
senior notes due 2029 (collectively, the “Notes”). IQVIA also
announced that the Issuer intends to deliver a notice of redemption
with respect to its outstanding 3.250% senior notes due 2025 (the
“3.250% Notes”).
The proceeds from the Notes offering will be used to redeem all
of the Issuer’s 3.250% Notes, including the payment of premiums in
respect thereof, and to pay fees and expenses related to the Notes
offering. The consummation of the Notes offering is subject to
market and other customary conditions.
Certain statements in this press release are forward-looking
statements. These statements involve a number of risks,
uncertainties and other factors, including the failure to
consummate the Notes offering and potential changes in market
conditions that could cause actual results to differ
materially.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy the Notes, nor shall there be any
offer, solicitation or sale of the Notes in any state or other
jurisdiction in which such offer, solicitation or sale would be
unlawful. The Notes to be offered have not been, and will not be,
registered under the Securities Act of 1933, as amended (the
“Securities Act”), or the securities laws of any other jurisdiction
and may not be offered or sold in the United States absent
registration or an applicable exemption from the registration
requirements of the Securities Act. The Notes are being offered
only to persons reasonably believed to be qualified institutional
buyers in the United States in reliance on Rule 144A under the
Securities Act and outside the United States only to non-U.S.
investors pursuant to Regulation S under the Securities Act. Any
offer of the Notes will be made only by means of a private offering
memorandum.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced
analytics, technology solutions, and clinical research services to
the life sciences industry. IQVIA creates intelligent connections
across all aspects of healthcare through its analytics,
transformative technology, big data resources and extensive domain
expertise. IQVIA Connected Intelligence™ delivers powerful insights
with speed and agility — enabling customers to accelerate the
clinical development and commercialization of innovative medical
treatments that improve healthcare outcomes for patients. With
approximately 70,000 employees, IQVIA conducts operations in more
than 100 countries.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors and
scientific advances, in an effort to advance their path toward
cures.
IQVIAFIN
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210216005532/en/
IQVIA Holdings Inc. Investor Relations: Andrew Markwick,
973-257-7144 andrew.markwick@iqvia.com or Media Relations: Tor
Constantino, 484-567-6732 tor.constantino@iqvia.com
IQVIA (NYSE:IQV)
Historical Stock Chart
From Aug 2024 to Sep 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From Sep 2023 to Sep 2024